Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Young

Showing results (151-160 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Human Genetics : EJHG|January 4, 2026
Impact of BRCA1/2 status on young women's sexual function, relationships, and reproduction after predictive genetic testingLaura E Forrest, Rowan Forbes Shepherd, Timothy Spelman, et al.
European Journal of Human Genetics : EJHG|March 17, 2005
Genetic professionals' reports of nondisclosure of genetic risk information within familiesAngus Clarke, Martin Richards, Lauren Kerzin-Storrar, et al.
Familial Cancer|July 4, 2006
Screening behavior in women at increased familial risk for breast cancerYoland C Antill, John Reynolds, Mary Anne Young, et al.
Cancer|October 13, 2004
A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutationsMary Jane Esplen, Jon Hunter, Molyn Leszcz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2010
Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipientsJudith Madigan, Dilys J Freeman, Fiona Menzies, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based studyLouise A Keogh, Melissa C Southey, Judi Maskiell, et al.
Familial Cancer|January 27, 2017
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Kate A McBride, Mandy L Ballinger, Timothy E Schlub, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group ReportJuan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 7, 2023
Development and evaluation of a novel educational program for providers on the use of polygenic risk scoresTatiane Yanes, Courtney K Wallingford, Mary-Anne Young, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2021
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behaviorTatiane Yanes, Bettina Meiser, Rajneesh Kaur, et al.
Pageof 19

Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Human Genetics : EJHG|January 4, 2026
Impact of BRCA1/2 status on young women's sexual function, relationships, and reproduction after predictive genetic testingLaura E Forrest, Rowan Forbes Shepherd, Timothy Spelman, et al.
European Journal of Human Genetics : EJHG|March 17, 2005
Genetic professionals' reports of nondisclosure of genetic risk information within familiesAngus Clarke, Martin Richards, Lauren Kerzin-Storrar, et al.
Familial Cancer|July 4, 2006
Screening behavior in women at increased familial risk for breast cancerYoland C Antill, John Reynolds, Mary Anne Young, et al.
Cancer|October 13, 2004
A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutationsMary Jane Esplen, Jon Hunter, Molyn Leszcz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2010
Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipientsJudith Madigan, Dilys J Freeman, Fiona Menzies, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based studyLouise A Keogh, Melissa C Southey, Judi Maskiell, et al.
Familial Cancer|January 27, 2017
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Kate A McBride, Mandy L Ballinger, Timothy E Schlub, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group ReportJuan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 7, 2023
Development and evaluation of a novel educational program for providers on the use of polygenic risk scoresTatiane Yanes, Courtney K Wallingford, Mary-Anne Young, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2021
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behaviorTatiane Yanes, Bettina Meiser, Rajneesh Kaur, et al.
Pageof 19